The Discounted Cash Flow (DCF) valuation of Biodesix, Inc. (BDSX) is (184.74) USD. With the latest stock price at 6.56 USD, the upside of Biodesix, Inc. based on DCF is -2916.2%.
Based on the latest price of 6.56 USD and our DCF valuation, Biodesix, Inc. (BDSX) is a sell. selling Biodesix, stocks now will result in a potential gain of 2916.2%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.9% - 9.6% | 7.7% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (765.69) - (108.96) | (184.74) |
| Upside | -11772.1% - -1761.0% | -2916.2% |